Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
Auron Therapeutics's investors include Eli Lilly, DCVC Bio, Apollo Health Ventures, Polaris Partners, Casdin Capital.
Auron Therapeutics is headquartered in Newton, United States.
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
Auron Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Auron Therapeutics — Funding & Investors." VCBacked, July 17, 2025, https://www.vcbacked.co/company/auron-therapeutics. Accessed September 13, 2026.
VCBacked. (2025). Auron Therapeutics — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/auron-therapeutics
{{cite web |title=Auron Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/auron-therapeutics |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated